Eye‐sparing multidisciplinary approach for the management of lacrimal gland carcinoma

@article{Esmaeli2016EyesparingMA,
  title={Eye‐sparing multidisciplinary approach for the management of lacrimal gland carcinoma},
  author={Bita Esmaeli and Vivian T. Yin and Ehab Y. Hanna and Merrill S. Kies and William N. William and Diana Bell and Steven J. Frank},
  journal={Head \& Neck},
  year={2016},
  volume={38}
}
We analyzed local control and early ocular toxicity after eye‐sparing management of lacrimal gland carcinoma. 
Outcomes after eye‐sparing surgery vs orbital exenteration in patients with lacrimal gland carcinoma
This study examined whether eye‐sparing surgery is associated with better or worse outcomes than exenteration for the treatment of lacrimal gland carcinomas.
Case of Adenoid Cystic Carcinoma of Lacrimal Gland Treated by Eye Sparing Radiation Therapy using 3DCRT Technique
TLDR
The following case illustrates the interdisciplinary approach to a rare tumor entity and the considerations made for preserving the orbital structures functionally.
Lacrimal gland adenoid cystic carcinoma: report of an unusual case with literature review
TLDR
A case of lacrimal gland adenoid cystic carcinoma treated with orbital exenteration and adjuvant volumetric modulated arc therapy is introduced, and the related literature is discussed.
Overview of benign and malignant lacrimal gland tumors
TLDR
Intra-arterial chemotherapy has been found to decrease recurrence and improve survival in ACC and can be used as part of an eye-sparing treatment strategy and the development of targeted drugs may offer palliation for patients with unresectable or metastatic disease in lacrimal gland carcinoma.
Current treatment of lacrimal gland carcinoma
TLDR
In selected patients with lacrimal gland carcinoma, eye- Sparing surgery with eye-sparing radiation therapy offers preservation of visual function with good local control and minimal radiation-induced ocular toxic effects, and a search for actionable cancer-associated mutations may be prudent.
Survival outcomes of eye-sparing surgery for adenoid cystic carcinoma of lacrimal gland
TLDR
This study highlighted the aggressive nature of adenoid cystic carcinoma of lacrimal glands and found that eye-sparing surgery with adjunctive radiotherapy may achieve relatively optimal disease control in diseases staged T1 or T2, but in advanced disease metastasis and mortality are usually inevitable.
Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma
TLDR
Eye-sparing tumor resection protocol followed by adjuvant therapy seems to be associated with high rates of local recurrence, metastases and death in Chinese patients with lacrimal gland adenoid cystic carcinoma with ≥ T3a tumors.
Adenoid cystic carcinoma of the lacrimal gland in a 14-year-old male
TLDR
A case of lacrimal gland ACC is reported in a 14-year-old male treated with neoadjuvant intra-arterial chemotherapy followed by globe-sparing tumor resection and chemoradiation and he remains disease free without evidence of tumor recurrence.
An Update on Tumors of the Lacrimal Gland.
TLDR
An update on the clinical, radiological, histological, and molecular features, along with treatment strategies for tumors of the lacrimal gland are presented.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 29 REFERENCES
Concurrent chemoradiation for adenoid cystic carcinoma of the head and neck
TLDR
A retrospective review of patients with nonresected head and neck adenoid cystic carcinoma treated with concurrent chemoradiation with positive results for ACC found no cause for concern.
Factors affecting the survival of patients with lacrimal gland tumours.
TLDR
In the 30 cases of benign mixed-cell tumour the results of total surgical removal of the affected gland were good: no recurrences were noted during a follow-up period of up to 12 years.
Neoadjuvant intracarotid chemotherapy for treatment of advanced adenocystic carcinoma of the lacrimal gland.
TLDR
The first report of the efficacy of neoadjuvant intracarotid chemotherapy in the treatment of an advanced adenocystic carcinoma of the lacrimal gland is reported, downstaging the disease in one case from intracranial involvement to a more surgically amenable intraorbital process.
Factors affecting the survival of patients with lacrimal gland tumours.
  • J. Wright
  • Medicine
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
  • 1982
TLDR
The clinical and pathological findings in 54 consecutive patients with primary tumours of the lacrimal gland are presented and the methods of treating these patients are described and the criteria used for choosing therapy discussed.
Epithelial malignancies of the lacrimal gland: survival rates after extensive and conservative therapy.
TLDR
A therapeutic protocol is suggested, in which all suspected epithelial tumors (discriminated from inflammatory and lymphoid lesions by computed tomographic scan findings) undergo dacryoadenectomy, without a previous biopsy, for lacrimal gland malignancies.
Adenoid cystic carcinoma of lacrimal gland.
TLDR
It is emphasized that radiotherapy in addition to surgical excision of the tumor is recommended because of its infiltrative nature.
Surgical Management of Locally Advanced Adenoid Cystic Carcinoma of the Lacrimal Gland
TLDR
Orbitectomy with bone removal may be indicated for achieving local and regional control in advanced cases of adenoid cystic carcinoma of the lacrimal gland, but this surgery does not decrease the risk of distant metastasis.
Epithelial tumors of the lacrimal gland: an update
Purpose of review The goal of this article is to offer an update on the treatment and prognosis of the most common epithelial tumors of the lacrimal gland, report on new pathological entities and
...
1
2
3
...